Get startedLog in
    Picture of Eagle Pharmaceuticals logo

    EGRX — Eagle Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Eagle Pharmaceuticals Provides Business Update And Guidance For 2023

    Picture of Eagle Pharmaceuticals logoEagle Pharmaceuticals
    10/01/2023 21:41
    Jan 10 (Reuters) - Eagle Pharmaceuticals Inc  EGRX.O :
    * EAGLE PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
GUIDANCE FOR
2023
    * SEES  FY 2023 ADJUSTED NON-GAAP EARNINGS PER SHARE OF
$4.20-$4.53
    * FY2023 EARNINGS PER SHARE VIEW $4.42 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX8Nr8Gm 
Further company coverage:  EGRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Eagle Pharmaceuticals

    See all news